PHILADELPHIA CHROMOSOME NEGATIVE ALL
Clinical trials for PHILADELPHIA CHROMOSOME NEGATIVE ALL explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME NEGATIVE ALL trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME NEGATIVE ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to cut chemo and boost survival in leukemia
Disease control Recruiting nowThis study tests whether adding CAR-T cells to standard chemotherapy can help adults newly diagnosed with a certain type of leukemia (Ph-negative B-ALL) achieve deeper remission and need fewer chemo cycles. About 77 participants will receive CAR-T cells after initial chemo. The g…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Promising combo aims to beat relapsed leukemia
Disease control Recruiting nowThis phase 2 trial tests whether adding a low dose of venetoclax (a targeted drug) with itraconazole to standard chemotherapy can improve remission rates in people with relapsed or refractory acute lymphoblastic leukemia. The study enrolls 12 adults whose leukemia has returned or…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC